Literature DB >> 31686279

Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.

Yue Ding1, Qiang Zou1, Yiting Jin1, Jian Zhou1, Hongying Wang2.   

Abstract

BACKGROUND: Parathyroid glands consist of chief cells and oxyphil cells. The parathyroid oxyphil cell proportion increased dramatically in patients with chronic kidney disease (CKD). The importance of the oxyphil cell in the treatment of secondary hyperparathyroidism (SHPT) has been enhanced in recent years. The aim of this study was to explore the possible relationship between parathyroid oxyphil cell proportion and clinical features of patients with CKD.
METHODS: From December 2010 to December 2018, 78 consecutive patients with CKD 5 who underwent parathyroidectomy (PTX) were reviewed. None of the patients had used Cinacalcet. Patients were divided into two groups according to their parathyroid oxyphil cell proportion. The mean parathyroid oxyphil cell proportion of all the patients was obtained. Group 1 consisted of 37 patients, the parathyroid oxyphil cell proportion of whom was more than or equal to mean proportion. Group 2 consisted of 41 patients, the parathyroid oxyphil cell proportion of whom was less than mean proportion. The demographic and biochemical data of the two groups were compared.
RESULTS: Preoperative parathyroid hormone (PTH) and total weight of removed parathyroid glands in the patients of group 1were less than those in group 2. There was no difference between the two groups in terms of preoperative calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), age and dialysis years.
CONCLUSION: The parathyroid oxyphil cell proportion was associated with preoperative PTH and total weight of removed parathyroid glands in the patients with CKD. Patients with more parathyroid oxyphil proportion had lower preoperative PTH level and smaller total weight of the removed parathyroid glands.

Entities:  

Keywords:  Chronic kidney disease; Oxyphil cell; Secondary hyperparathyroidism

Year:  2019        PMID: 31686279     DOI: 10.1007/s11255-019-02330-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

Review 1.  Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers.

Authors:  E M Brown
Journal:  Physiol Rev       Date:  1991-04       Impact factor: 37.312

2.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

Authors:  Paolo Raggi; Amy Boulay; Scott Chasan-Taber; Naseem Amin; Maureen Dillon; Steven K Burke; Glenn M Chertow
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.

Authors:  Keiichi Sumida; Michio Nakamura; Yoshifumi Ubara; Yuji Marui; Kiho Tanaka; Kenmei Takaichi; Shinji Tomikawa; Naoko Inoshita; Kenichi Ohashi
Journal:  J Clin Pathol       Date:  2011-05-12       Impact factor: 3.411

4.  Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.

Authors:  Cynthia Ritter; Brent Miller; Daniel W Coyne; Diptesh Gupta; Sijie Zheng; Alex J Brown; Eduardo Slatopolsky
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

5.  The parathyroid oxyphil cells.

Authors:  A C Christie
Journal:  J Clin Pathol       Date:  1967-07       Impact factor: 3.411

6.  The function of the parathyroid oxyphil cells in uremia: still a mystery?

Authors:  Carlo Basile; Carlo Lomonte
Journal:  Kidney Int       Date:  2017-11       Impact factor: 10.612

7.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

8.  Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases.

Authors:  Lori A Erickson; Long Jin; Mauro Papotti; Ricardo V Lloyd
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

9.  Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.

Authors:  Sharon M Moe; John Cunningham; Jürgen Bommer; Stephen Adler; Steven J Rosansky; Pablo Urena-Torres; Moetaz B Albizem; Matthew D Guo; Valter J Zani; William G Goodman; Stuart M Sprague
Journal:  Nephrol Dial Transplant       Date:  2005-07-19       Impact factor: 5.992

10.  Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?

Authors:  Jacques Rottembourg; Fabrice Menegaux
Journal:  Clin Kidney J       Date:  2018-07-23
View more
  1 in total

Review 1.  Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.

Authors:  Tally Naveh-Many; Oded Volovelsky
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.